Abstract
Background: Abram needle used for pleural biopsy since 1955, which used by both hands during the procedure. A new Esmat pleural biopsy needle has been invented 2013 that can be used with one hand with no assistance to take care of the wound during the procedure.
Objectives: evaluate the diagnostic yield of new esmat pleural biopsy needle in diagnosis of exudative pleural effusion.
Methods: prospective study of blind pleural biopsy for 20 patients with exudative pleural effusions not diagnosed by full analysis of the fluid using new Esmat pleural biopsy needl.
Design: 20 patient with undiagnosed pleural effusion after full analysis of the pleural fluid, they underwent parietal pleural biopsy using the new Esmat pleural biopsy needle with follow up for 2 months after the procedure.
Results: 20 patients: 12male and 8females with age mean ± SD is 53.5 ± 14.48 yrs. The diagnostic yield of Esmat pleural biopsy in tuberculous effusion, methothelioma and metastsatic adenocarcinoma were 100%, 71%, and 50% respectively. With total75% diagnostic yield in tubercolous and malignant effusions. 2 patients had rim of pneumothorax by chest x-ray that resolved spontaneously within 3 days, 4 patients complained of local chest pain for 2 days after the procedure.
Conclusion: the new Esmat pleural biopsy needle is safe, simple, easily used with one hand with a good diagnostic yield with low risk of complications.
- Copyright ©the authors 2016